YD Bio Limited(YDES)
$4.83-0.05 (-1.02%)
YDES
YD Bio Limited financials statements
$4.83
At close:-0.05 (-1.02%)
Want to see YDES full AI Analyst Report?
YD Bio Limited (YDES) Ratios
21 Followers
YD Bio Limited Ratios
YDES's free cash flow for Q2 2025 was $-298.19K. For the 2025 fiscal year, YDES's free cash flow was increased by $0.00 and operating cash flow was $-298.19K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.88 | 13.18 | 0.91 | 0.04 | 0.06 |
| Quick Ratio | 4.74 | 13.04 | 0.68 | 0.04 | 0.06 |
| Cash Ratio | 3.66 | 11.91 | 0.29 | 0.00 | 0.00 |
| Solvency Ratio | -0.49 | -4.77 | 0.05 | 0.56 | 0.96 |
| Operating Cash Flow Ratio | -4.01 | -6.98 | -0.19 | -0.54 | -0.34 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -6333.86 | -1.62 | 0.00 | 0.00 |
| Net Current Asset Value | $ -6.96M | $ 3.19M | $ -26.49K | $ -6.53M | $ -8.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -0.00 | 0.00 | 2.07 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | -0.00 | 0.00 | 0.67 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -4.83 | 1.04 | 13.97 | 1.60 | 1.08 |
| Debt Service Coverage Ratio | 0.00 | -1229.80 | 0.50 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -1893.69 | -4.59 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.74 | 2.43 | -1.78 | -0.00 | -0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | -7.06% | 30.44% | 43.83% | 0.00% | 0.00% |
| EBIT Margin | -1392.86% | -271.52% | 5.65% | 0.00% | 0.00% |
| EBITDA Margin | -1357.75% | -250.99% | 6.35% | 0.00% | 0.00% |
| Operating Profit Margin | -883.31% | -286.45% | -2.81% | 0.00% | 0.00% |
| Pretax Profit Margin | -1392.86% | -271.67% | 5.04% | 0.00% | 0.00% |
| Net Profit Margin | -1392.61% | -276.58% | 3.87% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -1392.61% | -276.58% | 3.87% | 0.00% | 0.00% |
| Net Income Per EBT | 99.98% | 101.81% | 76.83% | 99.94% | 100.00% |
| EBT Per EBIT | 157.69% | 94.84% | -179.24% | -163.15% | -505.35% |
| Return on Assets (ROA) | -60.32% | -20.56% | 4.22% | 21.12% | 7.37% |
| Return on Equity (ROE) | 291.05% | -21.42% | 58.97% | 33.83% | 7.99% |
| Return on Capital Employed (ROCE) | -43.44% | -22.15% | -42.82% | -18.76% | -1.48% |
| Return on Invested Capital (ROIC) | -43.41% | -22.09% | -10.72% | -18.75% | -1.48% |
| Return on Tangible Assets | -74.41% | -33.74% | 4.22% | 21.12% | 7.37% |
| Earnings Yield | -1.02% | -2.83% | 0.00% | 3.39% | 4.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.84 | 1.94 | 3.56 | 0.00 | 0.00 |
| Payables Turnover | 1.55 | 13.27 | 10.94 | 0.00 | 0.00 |
| Inventory Turnover | 0.34 | 9.51 | 2.83 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.80 | 5.79 | 24.48 | 0.00 | 0.00 |
| Asset Turnover | 0.04 | 0.07 | 1.09 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.11 | 0.32 | -0.13 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1273.18 | 198.84 | 198.05 | 0.00 | 0.00 |
| Days of Sales Outstanding | 435.60 | 187.95 | 102.61 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 1073.66 | 38.39 | 128.80 | 0.00 | 0.00 |
| Days of Payables Outstanding | 236.09 | 27.50 | 33.36 | 0.00 | 0.00 |
| Operating Cycle | 1509.26 | 226.33 | 231.41 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.10 | -0.44 | -0.00 | -0.33 | -0.05 |
| Free Cash Flow Per Share | -0.12 | -1.15 | -0.00 | -0.33 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -4.58 | -0.63 | -191.92 | 0.00 | -137683.00 |
| Capital Expenditure Coverage Ratio | -4.58 | -0.63 | -191.92 | 0.00 | -137683.00 |
| Operating Cash Flow Coverage Ratio | -975.27 | -81.44 | -1.17 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -11.05 | -3.60 | -0.16 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.99% | -9.51% | -0.01% | -2.70% | -0.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -101.58 | -21.50 | 62238.11 | 29.54 | 20.24 |
| Price-to-Sales (P/S) Ratio | 1362.74 | 97.81 | 2410.38 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -284.80 | 7.57 | 36703.00 | 9.99 | 1.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -101.20 | -10.51 | -15084.79 | -37.02 | -255.89 |
| Price-to-Operating Cash Flow Ratio | -123.29 | -27.18 | -15163.39 | -37.02 | -255.89 |
| Price-to-Earnings Growth (PEG) Ratio | 1.29 | 0.00 | -622.68 | -0.97 | -0.05 |
| Enterprise Value Multiple | -99.63 | -36.54 | 37935.32 | 29.52 | 20.24 |
| Enterprise Value | 807.31M | 46.81M | 843.91M | 111.89M | 176.15M |
| EV to EBITDA | -99.63 | -36.54 | 37935.32 | 29.52 | 20.24 |
| EV to Sales | 1352.69 | 91.71 | 2410.27 | 0.00 | 0.00 |
| EV to Free Cash Flow | -100.45 | -9.86 | -15084.08 | -37.01 | -255.88 |
| EV to Operating Cash Flow | -122.38 | -25.48 | -15162.68 | -37.01 | -255.88 |
| Tangible Book Value Per Share | -0.08 | 0.94 | 0.00 | 1.20 | 7.45 |
| Shareholders’ Equity Per Share | -0.04 | 1.59 | 0.00 | 1.20 | 7.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.02 | 0.23 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.12 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.12 | -0.34 | 0.00 | 0.41 | 0.59 |
| Tax Burden | 1.00 | 1.02 | 0.77 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.89 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.68 | 0.96 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 6.08 | 2.21 | 0.44 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 1.30 | -4.10 | -0.80 | -0.08 |
Currency in USD

